EGFR and lung cancer: On the other side, evidence suggests that lung cancers occurring in individuals who have never smoked (LCINS) is driven by oncogenic mutations, most often involving epidermal growth factor receptor (EGFR) [32, 33], indicating that LCINS may be genomically and molecularly distinct from smoking-related lung cancers.